tirzepatide children Once Weekly in and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 FDA reconsidering its decision to

DRUG THERAPY A number of chemical agents can produce oral melanin pigmentation

When asked about the utility of gastric POCUS to increase the quality of care of patients taking a GLP-1 RA, most respondents reported that they were somewhat interested (46%, n = 108), followed by very interested (24%, n = 56), not interested (20%, n = 47), and I am currently enrolled in or recently finished a POCUS program (11%, n = 25) (Table 9)

If youre considering an oral, clinically studied option, ask your clinician whether trial participants were similar to you and how real-world expectations might differ from trial results

There were two severe hypoglycemia events in each group and no diabetic ketoacidosis was reported